海泰新光收盘下跌1.15%，滚动市盈率41.07倍，总市值58.98亿元

Group 1 - The core viewpoint of the article highlights the performance and valuation of Qindao Haitai Newlight Technology Co., Ltd. in the medical device industry, noting its current stock price and market capitalization [1] - As of August 13, the company's stock closed at 49.2 yuan, down 1.15%, with a rolling price-to-earnings (PE) ratio of 41.07 times, and a total market value of 5.898 billion yuan [1] - The average PE ratio for the medical device industry is 57.48 times, with a median of 40.95 times, positioning Haitai Newlight at the 77th rank within the industry [1] Group 2 - As of the first quarter of 2025, nine institutions hold shares in Haitai Newlight, all of which are funds, with a total holding of 10.4214 million shares valued at 407 million yuan [1] - The company's main business includes the research, development, manufacturing, sales, and service of medical endoscope instruments and optical products, with key products being 4K fluorescence/white light laparoscopes, endoscope light source modules, and camera adapters/lenses [1] - The latest performance report for the first quarter of 2025 shows the company achieved an operating revenue of 147 million yuan, a year-on-year increase of 24.86%, and a net profit of 46.6887 million yuan, up 21.45%, with a gross profit margin of 64.98% [1]